Anna Kosinska
Overview
Explore the profile of Anna Kosinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehammer S, Greve M, Kosinski P, Kosinska A
Langmuir
. 2024 Nov;
40(47):25154-25165.
PMID: 39539166
In this work, we employed experimental technique to study the issue of particle erosion and deposition in multiphase flows involving both particles of micro/meso- and nanoscale (sand particles and iron...
2.
Michler T, Zillinger J, Hagen P, Cheng F, Festag J, Kosinska A, et al.
Antiviral Res
. 2024 Apr;
226:105896.
PMID: 38679167
Immune tolerance to the hepatitis B virus (HBV) is crucial for developing chronic hepatitis B, and the HBV surface antigen (HBsAg) produced and secreted in high amounts is regarded as...
3.
Kosinska A, Balakin B, Kosinski P
Sci Rep
. 2023 Oct;
13(1):17058.
PMID: 37816927
By using nanofluids as a working fluid in pump-free designs, thermal energy systems can become more efficient and have reduced maintenance costs, ultimately extending the system's lifespan. In this paper,...
4.
Kosinska A, Balakin B, Kosinski P
Sci Rep
. 2022 Mar;
12(1):3398.
PMID: 35233065
The paper is devoted to the topic of direct absorption solar collectors (DASCs). Various kinds of fluids can be used as heat transfer fluid in DASCs, and the main focus...
5.
Knolle P, Huang L, Kosinska A, Wohlleber D, Protzer U
Vaccines (Basel)
. 2021 Nov;
9(11).
PMID: 34835264
Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis...
6.
Lacorcia M, Bhattacharjee S, Laubhahn K, Alhamdan F, Ram M, Muschaweckh A, et al.
J Allergy Clin Immunol
. 2021 Mar;
148(3):843-857.e6.
PMID: 33684437
Background: Prenatal exposure to infections can modify immune development. These environmental disturbances during early life potentially alter the incidence of inflammatory disorders as well as priming of immune responses. Infection...
7.
Kosinski P, Balakin B, Kosinska A
Phys Rev E
. 2020 Sep;
102(2-1):022909.
PMID: 32942379
Discrete element methods require appropriate models for particle-particle collisions. Usually, researchers use soft-sphere types of models where the collision dynamics is solved numerically. This makes the simulation computationally expensive. In...
8.
Andruszkiewicz P, Zawadka M, Kosinska A, Walczak-Wieteska P, Majerowicz K
Anaesthesiol Intensive Ther
. 2017 Sep;
49(4):283-287.
PMID: 28953309
Background: Cricoid pressure is a standard anaesthetic procedure used to reduce the risk of aspiration of gastric contents during the induction of general anaesthesia. However, for several years its validity...
9.
Zhang E, Kosinska A, Lu M, Yan H, Roggendorf M
Antiviral Res
. 2015 Oct;
123:193-203.
PMID: 26476376
Chronic hepatitis B (CHB) is currently treated with IFN-α and nucleos(t)ide analogues, which have many clinical benefits, but there is no ultimate cure. The major problem consists in the persistence...
10.
Liu J, Kosinska A, Lu M, Roggendorf M
Virol Sin
. 2014 Jan;
29(1):10-6.
PMID: 24452539
Chronic hepatitis B virus (CHB) is currently treated with either interferon-based or nucleot(s)ide-based antiviral therapies. However, treatment with pegylated interferon alpha results in a durable antiviral response in only about...